Wuhan General Group

Wuhan General Group

M2Bio Sciences, a company that develops innovative healthcare solutions through cannabis and mushroom-based sciences, with focus on psilocybin and cannabinoids, targeting drug discovery and treatment sales in anxiety, depression, ADHD.

Launch date
Employees
Market cap
€5.0k
Enterprise valuation
€5k (Public information from Sep 2024)
Reno Nevada (HQ)
Authorizing premium user...